Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy
Adv Rheumatol; 59 (), 2019
Abstract Introduction: Antiphospholipid antibodies (aPL) are described in individuals with leprosy without the clinical features of antiphospholipid antibody syndrome (APS), a condition involving thromboembolic phenomena. We have described the persistence of these antibodies for over 5 years in patients...